Neurocrine Bioscience buy Cantor Fitzgerald
Start price
10.04.24
/
50%
€129.55
Target price
10.04.25
€144.01
Performance (%)
-37.71%
End price
11.04.25
€80.70
Summary
This prediction ended on 11.04.25 with a price of €80.70. Massive losses of -37.71% were the result for the BUY prediction by Cantor_Fitzgerald. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | -2.750% | -2.750% | -15.158% |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $155.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Cantor_Fitzgerald for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€110.65
16.09.24
16.09.24
€139.30
16.09.25
16.09.25
6.46%
17.09.25
17.09.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€116.40
29.08.24
29.08.24
€139.79
29.08.25
29.08.25
1.59%
30.08.25
30.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€136.10
25.07.24
25.07.24
€142.68
25.07.25
25.07.25
-17.38%
26.07.25
26.07.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.25
13.09.23
13.09.23
€126.70
13.09.24
13.09.24
-0.05%
14.09.24
14.09.24